Publications by: Tan N. Doan

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0 [feed] RSS 2.0
Number of items: 4.

Doan, Tan N., Fox, Greg J., Meehan, Michael T., Scott, Nick, Ragonnet, Romain, Viney, Kerri, Trauer, James M., and McBryde, Emma S. (2019) Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study. Journal of Antimicrobial Chemotherapy, 74 (1). pp. 218-227.

Doan, Tan N., Cao, Pengxing, Emeto, Theophilus I., Mccaw, James M., and McBryde, Emma S. (2018) Predicting the outcomes of new short-course regimens for multi-drug resistant tuberculosis using intrahost and pharmacokinetic-pharmacodynamic modelling. Antimicrobial Agents and Chemotherapy. (In Press)

McBryde, Emma S., Meehan, Michael T., Doan, Tan N., Ragonnet, Romain, Marais, Ben J., Guernier, Vanina, and Trauer, James M. (2017) The risk of global epidemic replacement with drug-resistant Mycobacterium tuberculosis strains. International Journal of Infectious Diseases, 56. pp. 14-20.

Doan, Tan N., Eisen, Damon P., Rose, Morgan T., Slack, Andrew, Stearnes, Grace, and McBryde, Emma S. (2017) Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: a latent-class analysis. PLoS One, 12 (11). e0188631.

This list was generated on Fri Apr 19 20:15:48 2019 AEST.